Brief: Painchek Says Meeting With FDA Agreeing A Revised Timeline For US De Novo Regulatory Clearance
05/06/2025 02:02
June 5 (Reuters) - PainChek Ltd PCK.AX: MEETING WITH FDA AGREEING A REVISED TIMELINE FOR US DE NOVO REGULATORY CLEARANCE DECISION Further company coverage: PCK.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on PainChek
See all newsBrief: Painchek Secures Initial Sabra Us Care Facilities
Brief: Painchek Says Lil Bianchi Appointed Non-Executive Chair
Australia's PainChek surges on fundraising for North America expansion
Australia's PainChek gains most in nearly 7 years on fresh funds for housing facility
Brief: PainChek Says Sabra To Fund Co Across Its 329 Skilled Nursing, Other Facilities In US, Canada